Tamoxifen Citrate

Overview

Tamoxifen Citrate is a nonsteroidal antiestrogen that is used in the treatment of breast cancer. It acts as a selective estrogen receptor modulator that blocks estrogen effects in the breast tissue.

API suppliers (14)

Suppliers of Tamoxifen Citrate evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• EXCELLA GMBH AND CO KGGermany1 active DMF
• OLON SPAItaly1 active DMF GMP on record
• YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU HAICI BIOLOGICAL PHARMACEUTICAL CO LTDChina1 active DMF
• TAPI NL BVNetherlands1 active DMF
• APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
• PCASFrance GMP on record
• Asymchem Laboratories (Tianjin) Co., Ltd.China
• LACHEMA BRNO
• CHEMICAL PHARMACEUTICAL RESEARCH INSTITUTE NIHFI LTD
• YANGTZE RIVER PHARMACY GROUP JIANGSU HAI CI BIOLOGICAL PHARMACY CO LTD
• LEIRAS PHARMACEUTICALS
• FUJISAWA DEUTSCHLAND GMBH
• EGIS PHARMACEUTICALS PRIVATE LTD GMP on record
• FERMION OYFinland GMP on record

EU CEP holders (3)

Companies holding a valid EU Certificate of Suitability (CEP) for Tamoxifen Citrate, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Chemical identity

IUPAC name

2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine

Canonical SMILES

CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3

InChIKey

NKANXQFJJICGDU-QPLCGJKRSA-N

Therapeutic areas